The Food and Drug Administration has issued a public health advisory about the immunosuppressant drug, efalizumab (Raptiva) made by Genentech, Inc. Three deaths, possibly a fourth, are connected to use of the drug, used to treat chronic psoriasis.
Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery. We are committed to serving the public with honesty and integrity in these efforts.
On the Road
Major Medical
Protecting Your Family
In the Workplace
Motley Rice Ranked A Best Law Firm by U.S. News and World Report
Tampa Toddler Dies After Being Left In Vehicle
Burn Advocates Network Returns From Mission In Haiti
Update: Burn Advocates Network In Haiti
Burn Advocates Network In Haiti